Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension

Completed · Phase 4

Conditions studied: Primary Open Angle Glaucoma, Ocular Hypertension

In brief

This is a multiple-dose study of the IOP-lowering efficacy of Azopt (brinzolamide) 1.0% compared to timolol 0.5% when added to a prostaglandin analogue (PGA) as adjunctive therapy over a 24 hour period in patients with glaucoma or ocular hypertension.

Key facts

Study ID

NCT00300079

Run by

Alcon Research

People needed

30

Starts

2006-09-01

Expected to finish

2007-09-01

Last updated by the study team

2016-11-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Primary open angle glaucoma or ocular hypertension patients

You may not qualify if…

• Women of childbearing potential
• History of bronchial asthma, or severe chronic obstructive pulmonary disease
• Presence of acute glaucoma

Where it is running

• Study site — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.